Search results for "ion therapy"

showing 10 items of 1072 documents

AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement.

2020

Lysosomal storage diseases (LSDs) are a heterogeneous group of inherited disorders caused by loss-of-function mutations in genes encoding for lysosomal enzymes/proteins. The consequence is a progressive accumulation of substrates in these intracellular organelles, resulting in cellular and tissue damage. The overall incidence is about 1/8000 live births, but is likely underestimated. LSDs are chronic progressive multi-systemic disorders, generally presenting with visceromegaly, and involvement of the central nervous system, eyes, the skeleton, and the respiratory and cardiovascular systems. The age at onset and phenotypic expression are highly variable, according to the specific enzymatic d…

AdultHepatosplenomegalyLysosomal acid lipase deficiencyBioinformaticsOrganomegaly03 medical and health sciencesLiver disease0302 clinical medicinemedicineCholesteryl ester storage disease Enzyme replacement therapy Gaucher disease Lysosomal acid lipase Niemann–Pick disease deficiency Substrate reduction therapyHumansSubstrate reduction therapyEnzyme Replacement TherapySocieties MedicalNiemann-Pick DiseasesAcid sphingomyelinase deficiencyGaucher DiseaseHepatologybusiness.industryGastroenterologyWolman DiseaseEnzyme replacement therapymedicine.diseaseLysosomal Storage DiseasesSphingomyelin PhosphodiesteraseItaly030220 oncology & carcinogenesis030211 gastroenterology & hepatologymedicine.symptombusinessNiemann–Pick diseaseLysosomesVisceromegalyDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C

2010

UNLABELLED 25-Hydroxyvitamin D (25[OH]D) can potentially interfere with inflammatory response and fibrogenesis. Its role in disease progression in chronic hepatitis C (CHC) and its relation with histological and sustained virological response (SVR) to therapy are unknown. One hundred ninety-seven patients with biopsy-proven genotype 1 (G1) CHC and 49 healthy subjects matched by age and sex were consecutively evaluated. One hundred sixty-seven patients underwent antiviral therapy with pegylated interferon plus ribavirin. The 25(OH)D serum levels were measured by high-pressure liquid chromatography. Tissue expression of cytochrome (CY) P27A1 and CYP2R1, liver 25-hydroxylating enzymes, were as…

AdultLiver CirrhosisMaleVITAMIN D CHRONIC HEPATITIS Cmedicine.medical_specialtyGenotypeCombination therapyHepacivirusSettore MED/08 - Anatomia PatologicaGastroenterologychemistry.chemical_compoundBlood serumRisk FactorsPegylated interferonInternal medicineRibavirinmedicineVitamin D and neurologyHumansVitamin DCytochrome P450 Family 2AgedSettore MED/12 - GastroenterologiaHepatologybusiness.industryRibavirinHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseasechemistryImmunologyCholestanetriol 26-MonooxygenaseFemaleInterferonsSteatosisbusinessViral hepatitismedicine.drug
researchProduct

Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial.

2002

Deferiprone has been suggested as an effective oral chelation therapy for thalassemia major. To assess its clinical efficacy, we compared deferiprone with deferoxamine in a large multicenter randomized clinical trial. One-hundred forty-four consecutive patients with thalassemia major and serum ferritin between 1500 and 3000 ng/ml were randomly assigned to deferiprone (75 mg/kg/day) (n = 71) or deferoxamine (50 mg/kg/day) (n = 73) for 1 year. The main measure of efficacy was the reduction of serum ferritin. Liver and heart iron contents were assessed by magnetic resonance. Liver iron content and fibrosis stage variations were assessed on liver biopsy by the Ishak score in all patients willin…

AdultLiver CirrhosisMalemedicine.medical_specialtyIron OverloadAdolescentPyridonesThalassemiaDeferoxamineIron Chelating AgentsGastroenterologylaw.inventionchemistry.chemical_compoundLeukocytopeniaRandomized controlled triallawInternal medicinemedicineHumansDeferiproneChelation therapyMolecular Biologymedicine.diagnostic_testbusiness.industrybeta-ThalassemiaCell BiologyHematologymedicine.diseaseIshak ScoreSurgeryDeferoxamineTreatment OutcomechemistryTherapeutic EquivalencyLiver biopsyFerritinsMolecular MedicineFemaleDeferipronebusinessmedicine.drugBlood cells, moleculesdiseases
researchProduct

What proportion of chronic obstructive pulmonary disease outpatients is eligible for inclusion in randomized clinical trials?

2013

<b><i>Background and Objective:</i></b> We aimed to explore to what extent an unselected population of chronic obstructive pulmonary disease (COPD) outpatients would be eligible for inclusion in randomized clinical trials (RCTs). <b><i>Methods:</i></b> Retrospective analysis of the clinical records of outpatient subjects with an ascertained diagnosis of COPD. COPD outpatients were assessed against the following inclusion criteria: 40 < age < 80 years, current or former smokers, forced expiratory volume in the first second (FEV<sub>1</sub>) <70% predicted, no long-term oxygen therapy, no other concomitant lung diseases and …

AdultLung DiseasesMalePulmonary and Respiratory Medicinemedicine.medical_specialtyMEDLINEPulmonary diseaseComorbiditySettore MED/10 - Malattie Dell'Apparato Respiratoriolaw.inventionCohort StudiesPulmonary Disease Chronic ObstructiveRandomized controlled triallawForced Expiratory VolumeInternal medicinePragmatic Clinical Trials as TopicmedicineHumansCOPDAgedRandomized Controlled Trials as TopicRetrospective StudiesAged 80 and overCOPDbusiness.industryPatient SelectionSmokingAge FactorsOxygen Inhalation TherapyRetrospective cohort studyMiddle Agedmedicine.diseaseComorbidityBronchiectasisrespiratory tract diseasesPhysical therapyFemaleObservational studyCognition DisordersbusinessCohort study
researchProduct

Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients

2016

Summary Analysis of a polymorphism in mature microRNA-608 (rs4919510) in rectal cancer patients enrolled in a randomized phase II clinical trial identified patient subpopulations who might benefit from the use of an intensified neo-adjuvant treatment strategy with Cetuximab.

AdultMale0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyPathologyGenotypeColorectal cancermedicine.medical_treatmentOriginal ManuscriptSingle-nucleotide polymorphismPolymorphism Single Nucleotide03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmicroRNAmedicineHumansOncology & CarcinogenesisProgression-free survivalNeoadjuvant therapyAgedRetrospective StudiesCetuximabRectal Neoplasmsbusiness.industryChemoradiotherapyGeneral MedicineMiddle Agedmedicine.diseaseChemotherapy regimenNeoadjuvant Therapy3. Good healthRadiation therapyMicroRNAs030104 developmental biology030220 oncology & carcinogenesisFemalebusiness1112 Oncology And Carcinogenesismedicine.drug
researchProduct

Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of…

2020

BackgroundImmune checkpoint inhibition (ICI) is an essential treatment option in melanoma. Its outcome may be improved by a preceding radiation of metastases. This study aimed to investigate the impact of a preceding radiotherapy on the clinical outcome of ICI treatment.MethodsThis multicenter retrospective cohort study included patients who received anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) or anti-programmed cell death protein 1 (PD-1) ICI with or without preceding radiotherapy for unresectable metastatic melanoma. ICI therapy outcome was measured as best overall response (BOR), progression-free (PFS) and overall survival (OS). Response and survival analyses were adjusted …

AdultMale0301 basic medicineOncologyCancer Researchmedicine.medical_specialtySkin NeoplasmsMetastatic melanoma2435medicine.medical_treatmentProgrammed Cell Death 1 ReceptorImmunologyMedizin03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansImmunology and AllergyCTLA-4 Antigen1506Immune Checkpoint InhibitorsMelanomaradiotherapyRC254-282Survival analysisRetrospective StudiesClinical/Translational Cancer ImmunotherapyPharmacologybusiness.industryMelanomaConfoundingNeoplasms. Tumors. Oncology. Including cancer and carcinogensRetrospective cohort studyChemoradiotherapyMiddle Agedmedicine.diseaseProgression-Free SurvivalImmune checkpointRadiation therapy030104 developmental biologyOncology030220 oncology & carcinogenesisRelative riskMolecular MedicineFemalebusinessJournal for ImmunoTherapy of Cancer
researchProduct

Evaluation of the effect of an intervention on the nutritional status of hospitalized patients

2017

Abstract Background and objectives To compare the nutritional status of a population of hospitalized patients, divided into 2 different groups, both at admission and hospital discharge, and to assess the influence of nutritional alteration during the hospital stay. Material and methods Quasi-experimental study comprising 2 groups of patients (N = 581): an intervention group (n = 303), in which nurses received specific training on managing care methodology, and a control group (n = 278), in which nurses continued their usual dynamics. Each group was made up of 2 care units with patients from both surgical and medical specialties. Inclusion criteria: patients admitted to the selected units wi…

AdultMale0301 basic medicineSample selectionPediatricsmedicine.medical_specialtyHospitalized patientsPopulationNutritional Status03 medical and health sciences0302 clinical medicinePatient ageIntervention (counseling)Hospital dischargeHumansMedicineProspective Studies030212 general & internal medicineeducationAgedAged 80 and overeducation.field_of_study030109 nutrition & dieteticsbusiness.industryMalnutritionNutritional statusOdds ratioMiddle AgedHospitalizationNutrition AssessmentTreatment OutcomeFemaleNutrition TherapybusinessFollow-Up StudiesMedicina Clínica (English Edition)
researchProduct

Diagnosis of pre-sarcopenia from a single selectional crosscut at C3 region, using CT scans before radiotherapy

2019

espanolProposito: el proposito de este estudio fue diagnosticar la presarcopenia en pacientes con cancer que no disponen de imagenes por tomografia computarizada (TC) a nivel abdominal mediante un metodo novedoso basado en cortes a nivel cervical. Material y metodos: se analizaron y se compararon mediante unidades la masa muscular y la masa muscular esqueletica en 37 pacientes con cancer de pulmon y neoplasias del aparato digestivo superior que incluian cortes en la TC de planificacion a nivel de C3 y L3. La presarcopenia se identifico de acuerdo con los puntos de corte establecidos actualmente: ≤ 41 cm2/m2 para mujeres, ≤ 43 cm2/m2 en hombres con un IMC ≤ 25 kg/m2 y ≤ 53 cm2/m2 en hombres …

AdultMale0301 basic medicineSarcopeniaLung NeoplasmsEsophageal Neoplasmsmedicine.medical_treatmentTomografiaMedicine (miscellaneous)Radioteràpia030209 endocrinology & metabolismComputed tomographyCohort Studies03 medical and health sciences0302 clinical medicineStomach NeoplasmsmedicineHumansC3Lung cancerCàncerCancerAgedRetrospective StudiesAged 80 and over030109 nutrition & dieteticsNutrition and DieteticsRadiotherapymedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseSkeletal muscle massPancreatic NeoplasmsRadiation therapyL3SarcopeniaCT scansFemaleRadiotherapy treatmentTomography X-Ray ComputedbusinessNuclear medicine
researchProduct

Effects of cognitive-behavioral therapy with relaxation vs. imagery rescripting on psychophysiological stress responses of students with test anxiety…

2018

Background and objectives: Psychophysiological measures were assessed in university students during a test simulation before and after group treatment for test anxiety based on cognitive behavioral...

AdultMale050103 clinical psychologyImagery PsychotherapyPsychotherapistmedicine.medical_treatmentAnxietyRelaxation Therapylaw.inventionYoung Adult03 medical and health sciences0302 clinical medicineRandomized controlled triallawStress (linguistics)medicineHumans0501 psychology and cognitive sciencesTest anxietyCognitive Behavioral TherapyRelaxation (psychology)05 social sciencesCognitionmedicine.disease030227 psychiatryGroup treatmentTest (assessment)Cognitive behavioral therapyClinical PsychologyTreatment OutcomeTest Taking SkillsPsychotherapy GroupFemalePsychologyStress PsychologicalPsychotherapy Research
researchProduct

Effects of cognitive behavioral therapy with relaxation vs. imagery rescripting on test anxiety: A randomized controlled trial.

2016

Abstract Background Test anxiety is a common condition in students, which may lead to impaired academic performance as well as to distress. The primary objective of this study was to evaluate the effectiveness of two cognitive-behavioral interventions designed to reduce test anxiety. Test anxiety in the participants was diagnosed as social or specific phobia according to DSM-IV. Subsequently subjects were randomized to three groups: a moderated self-help group, which served as a control group, and two treatment groups, where either relaxation techniques or imagery rescripting were applied. Methods Students suffering from test anxiety were recruited at two German universities ( n =180). The …

AdultMale050103 clinical psychologyImagery PsychotherapyUniversitiesmedicine.medical_treatmentAnxietyRelaxation Therapylaw.inventionPhobic disorderSpecific phobiaGroup psychotherapy03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled triallawmedicineHumans0501 psychology and cognitive sciencesStudentsTest anxietyCognitive Behavioral Therapy05 social sciencesmedicine.diseaseAnxiety Disorders030227 psychiatryCognitive behavioral therapyDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologyDistressSelf-Help GroupsPhobic DisordersAnxietyFemalemedicine.symptomPsychologyClinical psychologyFollow-Up StudiesJournal of affective disorders
researchProduct